Tag Archive for: bone marrow cancer

The company said that the marketing authorization decision could come early next year.

GSK Plc said on Friday the U.S. Food and Drug Administration (FDA) has extended the review period by three months for a drug the British drugmaker gained through its $1.9 billion buyout of Sierra Oncology last year.

Nelarabine Injection ensures access to a lifesaving treatment that historically has been in shortage.

The drug will be sold under the brand Rezlidhia and indicated for treating acute myeloid leukemia in patients with a susceptible genetic mutation.